278 related articles for article (PubMed ID: 33099023)
1. Transcription factor EB: an emerging drug target for neurodegenerative disorders.
Song JX; Liu J; Jiang Y; Wang ZY; Li M
Drug Discov Today; 2021 Jan; 26(1):164-172. PubMed ID: 33099023
[TBL] [Abstract][Full Text] [Related]
2. The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases.
Jiao F; Zhou B; Meng L
CNS Neurosci Ther; 2023 Jan; 29(1):37-59. PubMed ID: 36184826
[TBL] [Abstract][Full Text] [Related]
3. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
[TBL] [Abstract][Full Text] [Related]
4. TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities.
Cortes CJ; La Spada AR
Neurobiol Dis; 2019 Feb; 122():83-93. PubMed ID: 29852219
[TBL] [Abstract][Full Text] [Related]
5. Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia.
Liu Y; Xue X; Zhang H; Che X; Luo J; Wang P; Xu J; Xing Z; Yuan L; Liu Y; Fu X; Su D; Sun S; Zhang H; Wu C; Yang J
Autophagy; 2019 Mar; 15(3):493-509. PubMed ID: 30304977
[TBL] [Abstract][Full Text] [Related]
6. TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications.
Gu Z; Cao H; Zuo C; Huang Y; Miao J; Song Y; Yang Y; Zhu L; Wang F
Neurobiol Dis; 2022 Oct; 173():105855. PubMed ID: 36031168
[TBL] [Abstract][Full Text] [Related]
7. Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer's Disease and Parkinson's Disease.
Yang J; Zhang W; Zhang S; Iyaswamy A; Sun J; Wang J; Yang C
Aging Dis; 2023 Jun; 14(3):652-669. PubMed ID: 37191408
[TBL] [Abstract][Full Text] [Related]
8. A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity
Wang Z; Yang C; Liu J; Chun-Kit Tong B; Zhu Z; Malampati S; Gopalkrishnashetty Sreenivasmurthy S; Cheung KH; Iyaswamy A; Su C; Lu J; Song J; Li M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098449
[No Abstract] [Full Text] [Related]
9. The Autophagy-Lysosomal Pathway in Neurodegeneration: A TFEB Perspective.
Martini-Stoica H; Xu Y; Ballabio A; Zheng H
Trends Neurosci; 2016 Apr; 39(4):221-234. PubMed ID: 26968346
[TBL] [Abstract][Full Text] [Related]
10. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases.
Palmieri M; Pal R; Nelvagal HR; Lotfi P; Stinnett GR; Seymour ML; Chaudhury A; Bajaj L; Bondar VV; Bremner L; Saleem U; Tse DY; Sanagasetti D; Wu SM; Neilson JR; Pereira FA; Pautler RG; Rodney GG; Cooper JD; Sardiello M
Nat Commun; 2017 Feb; 8():14338. PubMed ID: 28165011
[TBL] [Abstract][Full Text] [Related]
11. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition.
Song JX; Sun YR; Peluso I; Zeng Y; Yu X; Lu JH; Xu Z; Wang MZ; Liu LF; Huang YY; Chen LL; Durairajan SS; Zhang HJ; Zhou B; Zhang HQ; Lu A; Ballabio A; Medina DL; Guo Z; Li M
Autophagy; 2016 Aug; 12(8):1372-89. PubMed ID: 27172265
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy.
Rai SN; Tiwari N; Singh P; Mishra D; Singh AK; Hooshmandi E; Vamanu E; Singh MP
Front Neurosci; 2021; 15():777347. PubMed ID: 34970114
[TBL] [Abstract][Full Text] [Related]
13. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the multifaced function of transcription factor EB (TFEB) in human diseases: From molecular mechanism to pharmacological modulation.
Zhang L; Li Z; Zhang L; Qin Y; Yu D
Biochem Pharmacol; 2023 Sep; 215():115698. PubMed ID: 37482200
[TBL] [Abstract][Full Text] [Related]
15. TFEB Biology and Agonists at a Glance.
Chen M; Dai Y; Liu S; Fan Y; Ding Z; Li D
Cells; 2021 Feb; 10(2):. PubMed ID: 33562649
[TBL] [Abstract][Full Text] [Related]
16. YWHA/14-3-3 proteins recognize phosphorylated TFEB by a noncanonical mode for controlling TFEB cytoplasmic localization.
Xu Y; Ren J; He X; Chen H; Wei T; Feng W
Autophagy; 2019 Jun; 15(6):1017-1030. PubMed ID: 30653408
[TBL] [Abstract][Full Text] [Related]
17. A splicing variant of TFEB negatively regulates the TFEB-autophagy pathway.
Park JY; Sohn HY; Koh YH; Jo C
Sci Rep; 2021 Oct; 11(1):21119. PubMed ID: 34702966
[TBL] [Abstract][Full Text] [Related]
18. The important role of TFEB in autophagy-lysosomal pathway and autophagy-related diseases: a systematic review.
Song TT; Cai RS; Hu R; Xu YS; Qi BN; Xiong YA
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1641-1649. PubMed ID: 33629334
[TBL] [Abstract][Full Text] [Related]
19. Pseudoginsenoside F11 ameliorates the dysfunction of the autophagy-lysosomal pathway by activating calcineurin-mediated TFEB nuclear translocation in neuron during permanent cerebral ischemia.
Fu X; Liu Y; Zhang H; Yu X; Wang X; Wu C; Yang J
Exp Neurol; 2021 Apr; 338():113598. PubMed ID: 33422553
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases.
Sardiello M
Ann N Y Acad Sci; 2016 May; 1371(1):3-14. PubMed ID: 27299292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
